FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129333677> ?p ?o ?g. }

• W3129333677 endingPage "351" @default.
• W3129333677 startingPage "351" @default.
• W3129333677 abstract "Bladder cancer (BCa) is an endocrine-related tumour and the activation of androgen signalling pathways may promote bladder tumorigenesis. We summarized the available preclinical and clinical evidence on the implications of the manipulation of androgen signalling pathways on the outcomes of BCa therapies. A systematic review was performed in December 2020. We included papers that met the following criteria: original preclinical and clinical research; evaluating the impact of androgen signalling modulation on the outcomes of BCa therapies. Six preclinical and eight clinical studies were identified. The preclinical evidence demonstrates that the modulation of androgen receptor-related pathways has the potential to interfere with the activity of the Bacillus Calmette Guerin, doxorubicin, cisplatin, gemcitabine, and radiotherapy. The relative risk of BCa recurrence after transurethral resection of the bladder tumour (TURBT) is significantly lower in patients undergoing therapy with 5 alpha reductase inhibitors (5-ARIs) or androgen deprivation therapy (ADT) (Relative risk: 0.50, 95% CI: 0.30–0.82; p = 0.006). Subgroup analysis in patients receiving 5-ARIs revealed a relative risk of BCa recurrence of 0.46 (95% CI: 0.22–0.95; p = 0.040). A significant negative association between the ratio of T1 BCa patients in treated/control groups and the relative risk of BCa recurrence was observed. Therapy with 5-ARIs may represent a potential strategy aimed at reducing BCa recurrence rate, mainly in patients with low stage disease. Further studies are needed to confirm these preliminary data." @default.
• W3129333677 created "2021-03-01" @default.
• W3129333677 creator A5001087651 @default.
• W3129333677 creator A5006080772 @default.
• W3129333677 creator A5009413506 @default.
• W3129333677 creator A5024289541 @default.
• W3129333677 creator A5025630288 @default.
• W3129333677 creator A5031699531 @default.
• W3129333677 creator A5032217427 @default.
• W3129333677 creator A5042911985 @default.
• W3129333677 creator A5051536719 @default.
• W3129333677 creator A5053142267 @default.
• W3129333677 creator A5055022840 @default.
• W3129333677 creator A5069957432 @default.
• W3129333677 creator A5072253946 @default.
• W3129333677 creator A5073386345 @default.
• W3129333677 creator A5073972309 @default.
• W3129333677 date "2021-02-20" @default.
• W3129333677 modified "2023-10-18" @default.
• W3129333677 title "Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies" @default.
• W3129333677 cites W1491207647 @default.
• W3129333677 cites W1633535281 @default.
• W3129333677 cites W1912481925 @default.
• W3129333677 cites W2018146261 @default.
• W3129333677 cites W2023023921 @default.
• W3129333677 cites W2060690469 @default.
• W3129333677 cites W2194426324 @default.
• W3129333677 cites W2290409124 @default.
• W3129333677 cites W2293098307 @default.
• W3129333677 cites W2403608015 @default.
• W3129333677 cites W2426061205 @default.
• W3129333677 cites W2473162054 @default.
• W3129333677 cites W2503810307 @default.
• W3129333677 cites W2531269403 @default.
• W3129333677 cites W2554427572 @default.
• W3129333677 cites W2589780548 @default.
• W3129333677 cites W2748444903 @default.
• W3129333677 cites W2794791637 @default.
• W3129333677 cites W2799619112 @default.
• W3129333677 cites W2800291589 @default.
• W3129333677 cites W2893915749 @default.
• W3129333677 cites W2945390891 @default.
• W3129333677 cites W2965386530 @default.
• W3129333677 cites W2986610052 @default.
• W3129333677 cites W2997488840 @default.
• W3129333677 cites W3008920943 @default.
• W3129333677 cites W3022903699 @default.
• W3129333677 cites W3027723605 @default.
• W3129333677 cites W3038159597 @default.
• W3129333677 cites W3046692122 @default.
• W3129333677 cites W3084094503 @default.
• W3129333677 cites W3096123211 @default.
• W3129333677 cites W3103967889 @default.
• W3129333677 doi "https://doi.org/10.3390/diagnostics11020351" @default.
• W3129333677 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7923424" @default.
• W3129333677 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33672461" @default.
• W3129333677 hasPublicationYear "2021" @default.
• W3129333677 type Work @default.
• W3129333677 sameAs 3129333677 @default.
• W3129333677 citedByCount "16" @default.
• W3129333677 countsByYear W31293336772021 @default.
• W3129333677 countsByYear W31293336772022 @default.
• W3129333677 countsByYear W31293336772023 @default.
• W3129333677 crossrefType "journal-article" @default.
• W3129333677 hasAuthorship W3129333677A5001087651 @default.
• W3129333677 hasAuthorship W3129333677A5006080772 @default.
• W3129333677 hasAuthorship W3129333677A5009413506 @default.
• W3129333677 hasAuthorship W3129333677A5024289541 @default.
• W3129333677 hasAuthorship W3129333677A5025630288 @default.
• W3129333677 hasAuthorship W3129333677A5031699531 @default.
• W3129333677 hasAuthorship W3129333677A5032217427 @default.
• W3129333677 hasAuthorship W3129333677A5042911985 @default.
• W3129333677 hasAuthorship W3129333677A5051536719 @default.
• W3129333677 hasAuthorship W3129333677A5053142267 @default.
• W3129333677 hasAuthorship W3129333677A5055022840 @default.
• W3129333677 hasAuthorship W3129333677A5069957432 @default.
• W3129333677 hasAuthorship W3129333677A5072253946 @default.
• W3129333677 hasAuthorship W3129333677A5073386345 @default.
• W3129333677 hasAuthorship W3129333677A5073972309 @default.
• W3129333677 hasBestOaLocation W31293336771 @default.
• W3129333677 hasConcept C121608353 @default.
• W3129333677 hasConcept C126322002 @default.
• W3129333677 hasConcept C143998085 @default.
• W3129333677 hasConcept C2777899217 @default.
• W3129333677 hasConcept C2777911890 @default.
• W3129333677 hasConcept C2780192828 @default.
• W3129333677 hasConcept C2780352672 @default.
• W3129333677 hasConcept C71315377 @default.
• W3129333677 hasConcept C71924100 @default.
• W3129333677 hasConcept C95190672 @default.
• W3129333677 hasConceptScore W3129333677C121608353 @default.
• W3129333677 hasConceptScore W3129333677C126322002 @default.
• W3129333677 hasConceptScore W3129333677C143998085 @default.
• W3129333677 hasConceptScore W3129333677C2777899217 @default.
• W3129333677 hasConceptScore W3129333677C2777911890 @default.
• W3129333677 hasConceptScore W3129333677C2780192828 @default.
• W3129333677 hasConceptScore W3129333677C2780352672 @default.
• W3129333677 hasConceptScore W3129333677C71315377 @default.

• next